Smith Hunter C's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Jun 3, 2025
- Accession no.
- 0001104659-25-055974
- Filed
- Jun 3, 2025
- Trade date
- May 30, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.44M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Hunter CCIK 0001636385 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | MOption exerciseAcquired | +23,400 | $6.88 | +$160,992 | 133,329 | Direct | |
| May 30, 2025 | Common Stock | SSaleDisposed | −4,407 | $60.93 | −$268,518.51 | 128,922 | Direct | |
| May 30, 2025 | Common Stock | SSaleDisposed | −18,993 | $61.52 | −$1,168,449.36 | 109,929 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | MOption exerciseDisposed | −23,400 | $0.00 | $0 | 77,194 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.